Market Snapshot
S&P Futures
3,779.5
Dow Futures
30,569
Nasdaq Futures
11,622.75
Aethlon Medical, Inc. (AEMD) stock declined over -3.81% intraday to trade at $1.01 a share on NASDAQ. The stock opened with a loss of -21.71% at $1.09 and touched an intraday high of $1.14, falling -9.82% against the last close of $1.12. The stock went to a low of $1.05 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-07-01 | $1.09 | $1.14 | $1.05 | $1.05 | 889,700 |
2022-06-30 | $1.29 | $1.35 | $1.02 | $1.12 | 1,416,200 |
2022-06-29 | $1.1 | $1.55 | $1.03 | $1.33 | 8,464,000 |
2022-06-28 | $1.08 | $1.18 | $1.08 | $1.17 | 390,300 |
2022-06-27 | $1.06 | $1.15 | $1.04 | $1.06 | 483,500 |
2022-06-24 | $1.07 | $1.12 | $1.05 | $1.1 | 459,800 |
2022-06-23 | $1.07 | $1.1 | $1.01 | $1.01 | 524,300 |
2022-06-22 | $0.99 | $1.08 | $0.99 | $1.02 | 199,200 |
2022-06-21 | $0.96 | $1.03 | $0.94 | $0.99 | 246,100 |
2022-06-17 | $1 | $1 | $0.95 | $0.96 | 161,500 |
Employees-
Beta0.89
Sales or Revenue315.28 Thousands
5Y Sales Change-5.60%
Fiscal Year Ends2021-03-30
SectorHealth Care
IndustryHealth Care Equipment
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.
Aethlon Medical, Inc. (NASDAQ: AEMD) stock price is $1.01 as of the last check on Friday, July 1. During the trading session, AEMD stock reached the peak price of $1.14 while $1.05 was the lowest point it dropped to.
The NASDAQ listed AEMD is part of Health Care Equipment industry that operates in the broader Health Care sector. Aethlon Medical, Inc. , a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States.
Dr. Charles J. Fisher Jr., M.D.
CEO, Director & Member of Extracorporeal Therapy Advisory Board
Mr. James B. Frakes M.B.A.
CFO, Sr. VP of Fin. & Sec.
Mr. Steven P. Larosa M.D.
Chief Medical Officer & Acting Chief Scientific Officer
Mr. Guy F. Cipriani BS (Eng.), MBA
Sr. VP, Chief Bus. Officer & Director
AEMD stock traded closed the last session at $1.05, which is $-0.04 or -3.81% lower than its previous close of $1.12. AEMD's current trading price is 14.77% lower than its 52-week high of $6.22 where as its distance from 52-week low of 0.88% is -83.76%.
Number of AEMD employees currently stands at -. AEMD operates from 9635 Granite Ridge Drive, Suite 100, San Diego, CA 92123, United States.
Official Webiste of $AEMD is: https://www.aethlonmedical.com
AEMD could be contacted at AEMD operates from 9635 Granite Ridge Drive, Suite 100, San Diego, CA 92123, United States, or at phone #858 459 7800 and can also be accessed through its website.
AEMD stock volume for the day was 174,831 shares while in the previous session number of AEMD shares traded was 889,700 . The average number of AEMD shares traded daily for last 3 months was 526.38 Thousands.
The percentage change in AEMD stock occurred in the recent session was -3.81% while the dollar amount for the price change in AEMD stock was $-0.04.
In the recent session, the day high for AEMD stock was $1.14 while the low for AEMD stock touched on the day was $1.05.
The market value of AEMD currently stands at 17.03 Million with its latest stock price at $1.01 and 15.83 Million of its shares outstanding.